Laddar...

Agomelatine as monotherapy for major depression: an outpatient, open-label study

BACKGROUND: Agomelatine is a novel antidepressant agonist to MT1 and MT2 subtypes of melatoninergic receptors (MT1 and MT2) and antagonist to 5-HT(2C) subtype of serotonergic (5-HT(2C)) receptors, which has shown antidepressant efficacy in short-term and long-term trials as well as in clinical pract...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Pecenak, Jan, Novotny, Vladimir
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2013
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3808155/
https://ncbi.nlm.nih.gov/pubmed/24174876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S49062
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!